Clinical Pediatrics

Allen Merritt, T.; Bauer, William I.; Hasselmeyer, Eileen G.

doi: 10.1177/000992287501401201pmid: 1192682

Janicki, R. S.; Garnham, J. C.; Worland, M. C.; Grundy, W. E.; Thomas, J. R.

doi: 10.1177/000992287501401202pmid: 1104241

The microbiologic and clinical responses of acute Group A beta-hemolytic streptococcal infections of the upper respiratory tract to oral treatment with erythromycin ethyl succinate, stearate, and estolate were studied in 303 patients. Streptococcal M and T typing was done on all positive cultures. The overall cure rate was 95.4 per cent, with no statistically significant differences in clearing organisms from the pharynx. Of the 285 cured patients who completed the prescribed follow-up period, 11 had recurrences between the 12th and 31st day after initiation of therapy, and five developed new infections. No cases of rheumatic fever or glomerulonephritis were encountered during a follow-up study. Eight gastrointestinal reactions and one transient rash occurred. Results with these forms of erythromycin compare favorably with published results for similar infections treated with oral penicillins.

Ali, Jameel; Riese, Karl T.

doi: 10.1177/000992287501401203pmid: 1104242

Shwachman, H.; Khaw, K-T.; Kowalski, S. M.

doi: 10.1177/000992287501401204pmid: N/A

Zepp, E. A.; Thomas, J. A.; Knotts, G. R.

doi: 10.1177/000992287501401205pmid: 169

English, Susan T.; Prutting, Carol A.

doi: 10.1177/000992287501401206pmid: 1192684

This remedial program of teaching infants with tracheostenosis to use American Sign Language appears to be a successful procedure for eliciting not only expressive language but also in aiding psychosocial-cognitive development.

Harlow, Mark; Chung, Stanley M. K.; Plotkin, Stanley A.

doi: 10.1177/000992287501401207pmid: 1081439

Shiono, Hiroshi; Kadowaki, Junichi; Fujiwara, Takeki; Nakao, Tooru

doi: 10.1177/000992287501401208pmid: 127683

Hepatitis-Associated (Australia) Antigen (HAA) was detected in 13 (5.8%) of 223 patients with Down's syndrome and in 14 (3.7%) of 378 patients with other forms of mental retardation. The frequency of HAA was 2.4 per cent in 127 noninstitutionalized patients with Down's syndrome, and 10.4 per cent in 96 institutionalized patients. The frequency of HAA with Down's syndrome was lower on the average in Japan than in the United States or Germany.HAA was detected in one (1.3%) of 78 mothers of infants with Down's syndrome. Our study suggests that maternal exposure to HAA, as reflected by the presence of either HAA or anti-HAA, was not associated with the subsequent birth of an infant with Down's syndrome.

Shapiro, Steven; Steier, Moshe; Dimich, Ivan

doi: 10.1177/000992287501401209pmid: 1192685

Stickler, Gunnar B.

doi: 10.1177/000992287501401210pmid: 127684